| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |